免疫组织化学和荧光原位杂交检测韩国女性早发性乳腺癌HER-2/ new癌基因的特征

Journal of Korean Breast Cancer Society Pub Date : 2003-12-01 DOI:10.4048/JKBCS.2003.6.4.255

D. Choi, M. H. Lee, Yongsoon Ahn, Dong Wha Lee, D. Shin, D. Carter, B. King, B. Haffty

{"title":"免疫组织化学和荧光原位杂交检测韩国女性早发性乳腺癌HER-2/ new癌基因的特征","authors":"D. Choi, M. H. Lee, Yongsoon Ahn, Dong Wha Lee, D. Shin, D. Carter, B. King, B. Haffty","doi":"10.4048/JKBCS.2003.6.4.255","DOIUrl":null,"url":null,"abstract":"ligand binding.(7) Over-expression of HER-2 has been shown test may be useful for selecting systemic chemotherapy in Korean patients with early onset breast cancer. And the specific anti-HER-2 therapy will be helpful to a large proportion of Korean patients who have more tumors with HER-2 overexpression than White patients. (Journal of Korean Breast Cancer Society 2003;6:255-262) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ","PeriodicalId":414717,"journal":{"name":"Journal of Korean Breast Cancer Society","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Characteristics of HER-2/neu Oncogene in Korean Women with Early-onset Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization\",\"authors\":\"D. Choi, M. H. Lee, Yongsoon Ahn, Dong Wha Lee, D. Shin, D. Carter, B. King, B. Haffty\",\"doi\":\"10.4048/JKBCS.2003.6.4.255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ligand binding.(7) Over-expression of HER-2 has been shown test may be useful for selecting systemic chemotherapy in Korean patients with early onset breast cancer. And the specific anti-HER-2 therapy will be helpful to a large proportion of Korean patients who have more tumors with HER-2 overexpression than White patients. (Journal of Korean Breast Cancer Society 2003;6:255-262) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ\",\"PeriodicalId\":414717,\"journal\":{\"name\":\"Journal of Korean Breast Cancer Society\",\"volume\":\"40 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Korean Breast Cancer Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4048/JKBCS.2003.6.4.255\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Breast Cancer Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4048/JKBCS.2003.6.4.255","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

(7)研究表明，HER-2过表达可能有助于韩国早发性乳腺癌患者选择全身化疗方案。特异性的抗HER-2治疗将对很大一部分HER-2过表达肿瘤多于白人的韩国患者有所帮助。(《社会2003年韩国乳腺癌;6:255 - 262)ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Characteristics of HER-2/neu Oncogene in Korean Women with Early-onset Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization

ligand binding.(7) Over-expression of HER-2 has been shown test may be useful for selecting systemic chemotherapy in Korean patients with early onset breast cancer. And the specific anti-HER-2 therapy will be helpful to a large proportion of Korean patients who have more tumors with HER-2 overexpression than White patients. (Journal of Korean Breast Cancer Society 2003;6:255-262) ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Korean Breast Cancer Society

自引率

0.00%

发文量